V03AC03 • deferasirox • Various | All other therapeutic products | Iron chelating agents
Deferasirox is an iron chelator used for the treatment of chronic iron overload in patients with frequent blood transfusions, such as those with major thalassemia. It works by binding excess iron, facilitating its elimination through feces.
The medication is taken orally, usually once daily, with the dose adjusted based on the body's iron levels and the patient's weight. Common side effects include nausea, diarrhea, abdominal pain, and elevated liver enzymes.
Deferasirox is contraindicated in patients with severe renal impairment, hepatic failure, or hypersensitivity to the active substance. Its use also requires regular monitoring of renal and hepatic function.
This medication is an effective option for managing iron overload, helping to prevent complications associated with this condition.
Substance: deferasirox
Date of last drug list: 01-06-2017
Commercial code: W63462003
Concentration: 90mg
Pharmaceutical form: tablets
Quantity: 300
Product type: original
Prescription restrictions: P-RF - Medicines prescription that is retained in the pharmacy (not renewable).